COVID-19 is a fast-growing worldwide danger that the WHO has classified as a pandemic. COVID-19 infects the patient's respiratory tract and causes pneumonia in the majority of patients. It can also cause acute respiratory distress or ARDS in roughly 15 percent of Covid-19 cases. The existence of the virus's so-called "cytokine storm" Covid-19 infection was therefore linked to death in patients.. Increased proinflammatory cytokine production exacerbates ARDS and causes significant tissue damage. Due to that fact, there is also the chance that It can cause multi-organ organ failure in certain circumstances. Using cytokines as a target during COVID-19 treatment might help patients live longer and die less. Due to the fact that IL-6 is one of the likely reported cytokines to be enhanced in people who are suffering from Covid-19. Also, it is proven that elevated IL-6 can be directly linked to higher levels of death, tocilizumab is the ideal solution as a therapy for a cytokine storm that can come with Covid-19.